好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Personalized Treatment for a Patient with a BRAF V600E-Mutation Using Dabrafenib and Tumor Treatment Fields (TTFields; NovoTTF -100A) Device in a Glioblastoma Arising from Ganglioglioma
Neuro-oncology
(-)
280
Authors/Disclosures
Isaac Melguizo-Gavilanes, MD
PRESENTER 		Dr. Melguizo-Gavilanes has nothing to disclose.
No disclosure on file
No disclosure on file
George J. Snipes, MD No disclosure on file
No disclosure on file
No disclosure on file
Roy H. Hamilton, MD, MS, FANA, FAAN Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognito Therapeutics. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
No disclosure on file
No disclosure on file
Norma Palma, DO No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file